COM:ADAPTIMMUNE
Adaptimmune Therapeutics plc
- Stock
Last Close
0.64
22/11 21:00
Market Cap
293.91M
Beta: -
Volume Today
1.34M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -14.37M - | -23.69M 64.83% | -71.58M 202.09% | -70.14M 2.01% | -95.51M 36.18% | -137.16M 43.61% | -130.09M 5.16% | -158.09M 21.52% | -165.46M 4.66% | -114.31M 30.91% | |
depreciation and amortization | 250.37K - | 732.79K 192.69% | 3.29M 348.43% | 5.42M 65.03% | 7.81M 44.02% | 8.01M 2.56% | 7.59M 5.19% | 6.57M 13.52% | 6.08M 7.49% | 9.86M 62.26% | |
deferred income tax | 1.22M - | -7.95M - | 12.22M 253.65% | 1.06M 91.30% | 2.50M 135.47% | 5.82M 132.36% | -41.91M - | ||||
stock based compensation | 349.15K - | 4.22M 1,108.37% | 8.82M 109.08% | 10.80M 22.48% | 16.20M 49.96% | 11.05M 31.78% | 10.41M 5.78% | 20.63M 98.09% | 18.24M 11.58% | 11.77M 35.46% | |
change in working capital | 49.78M - | -13.74M 127.59% | 12.50M 190.97% | 7.21M 42.32% | -45.34M 729.06% | 4.72M 110.40% | 56.05M 1,088.15% | 134.63M 140.22% | -1.53M 101.14% | -25.05M 1,536.10% | |
accounts receivables | -1.44M - | 1.76M 222.10% | -19.36M 1,199.39% | -9.81M 49.33% | -1.30M 86.78% | ||||||
inventory | -6.19M - | -5.66M 8.64% | 15.15M 367.76% | 5.40M 64.34% | -1 100.00% | ||||||
accounts payables | 7.63M - | 3.90M 48.95% | 4.21M 7.94% | 4.41M 4.73% | -9.12M 307.07% | ||||||
other working capital | 49.78M - | -13.74M 127.59% | 12.50M 190.97% | 7.21M 42.32% | -45.34M 729.06% | 4.72M 110.40% | 56.05M 1,088.15% | 134.63M 140.22% | -1.53M 101.14% | -14.63M 855.62% | |
other non cash items | 1.70K - | -257.89K 15,241.75% | -1.19M 362.21% | 341K 128.61% | 237K 30.50% | -185K 178.06% | -55K 70.27% | 1.17M 2,232.73% | 903K 23.02% | 18.21M 1,916.65% | |
net cash provided by operating activities | 37.23M - | -32.74M 187.93% | -48.17M 47.14% | -54.31M 12.76% | -104.39M 92.19% | -112.51M 7.78% | -53.59M 52.37% | 10.73M 120.02% | -141.77M 1,421.36% | -141.43M 0.24% | |
investments in property plant and equipment | -1.45M - | -5.11M 252.49% | -12.79M 150.24% | -25.01M 95.64% | -4.71M 81.18% | -3.07M 34.71% | -2.91M 5.47% | -8.78M 202.17% | -29.74M 238.69% | -4.90M 83.53% | |
acquisitions net | 1.28M - | 369K 71.15% | 798K 116.26% | 1.48M 85.71% | 565K 61.88% | 207K 63.36% | 77.86M 37,512.08% | 45.44M 41.64% | |||
purchases of investments | -55.30M - | -42.84M 22.53% | -171.33M 299.97% | -150.79M 11.99% | -27.28M 81.91% | -381.04M 1,296.57% | -139.76M 63.32% | -48.12M 65.57% | -76.25M 58.46% | ||
sales maturities of investments | 73.38M - | 69.72M 4.99% | 138.04M 98.00% | 125.30M 9.23% | 105.02M 16.19% | 224.34M 113.62% | 166.99M 25.56% | 211.80M 26.83% | |||
other investing activites | 124.23K - | -1.28M 1,129.56% | 181K 114.15% | -798K 540.88% | -1.48M 85.71% | -565K 61.88% | -207K 63.36% | -77.86M 37,512.08% | 1.13M 101.45% | ||
net cash used for investing activites | -1.45M - | -60.28M 4,058.98% | 17.75M 129.45% | -126.08M 810.12% | -17.46M 86.15% | 94.94M 643.88% | -278.92M 393.77% | 75.80M 127.18% | 89.14M 17.59% | 177.22M 98.82% | |
debt repayment | |||||||||||
common stock issued | 16.94M - | 274.74M 1,522.17% | 103.17M - | 99.65M 3.41% | 367.51K 99.63% | 334.39M 90,886.22% | 2.53M 99.24% | 12.82M 406.80% | 883.41K 93.11% | ||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 17K - | 401K 2,258.82% | 3.04M 657.36% | -1.51K 100.05% | 5.66M 373,895.38% | 759K 86.60% | 50K 93.41% | ||||
net cash used provided by financing activities | 16.94M - | 274.74M 1,522.17% | 17K 99.99% | 103.57M 609,123.53% | 102.69M 0.85% | 366K 99.64% | 340.05M 92,810.11% | 3.29M 99.03% | 12.87M 291.33% | 883.41K 93.13% | |
effect of forex changes on cash | -0.00 - | -0.00 3.70% | -5.58M 534,857,646,079,900% | 2.33M 141.73% | 3.33M 43.26% | -372K 111.15% | -960K 158.06% | 365K 138.02% | -2.30M 729.86% | 877K 138.15% | |
net change in cash | 52.72M - | 181.72M 244.70% | -35.98M 119.80% | -74.50M 107.09% | -15.82M 78.77% | -17.57M 11.05% | 6.58M 137.43% | 90.18M 1,271.38% | -42.06M 146.64% | 35.96M 185.48% | |
cash at beginning of period | -1.44M - | 47.34M 3,377.74% | 198.77M 319.88% | 162.80M 18.10% | 88.30M 45.76% | 72.48M 17.92% | 54.91M 24.24% | 61.48M 11.98% | 151.67M 146.68% | 108.03M 28.77% | |
cash at end of period | 51.27M - | 229.06M 346.74% | 162.80M 28.93% | 88.30M 45.76% | 72.48M 17.92% | 54.91M 24.24% | 61.48M 11.98% | 151.67M 146.68% | 109.60M 27.73% | 143.99M 31.38% | |
operating cash flow | 37.23M - | -32.74M 187.93% | -48.17M 47.14% | -54.31M 12.76% | -104.39M 92.19% | -112.51M 7.78% | -53.59M 52.37% | 10.73M 120.02% | -141.77M 1,421.36% | -141.43M 0.24% | |
capital expenditure | -1.45M - | -5.11M 252.49% | -12.79M 150.24% | -25.01M 95.64% | -4.71M 81.18% | -3.07M 34.71% | -2.91M 5.47% | -8.78M 202.17% | -29.74M 238.69% | -4.90M 83.53% | |
free cash flow | 35.78M - | -37.85M 205.77% | -60.95M 61.06% | -79.33M 30.14% | -109.10M 37.53% | -115.58M 5.94% | -56.50M 51.12% | 1.95M 103.45% | -171.51M 8,904.36% | -146.32M 14.68% |
All numbers in USD (except ratios and percentages)